{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Famindr.com%2Fepisodes%2F264-tau-protein-pathology-in-alzheimers-disease-december-2021-6FvKHCQK","width":444,"version":"1.0","type":"rich","title":"264 - Tau Protein Pathology in Alzheimer's Disease: December 2021","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/9a8ef428-72db-47cb-a5cb-a6a258a13785/1c1953d8-6709-405b-b299-a072ca5698b2/slide26-4.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/daa20fa7-3ecd-4af5-8da4-39ef04ab0fb5\" height=\"200\" width=\"100%\" title=\"264 - Tau Protein Pathology in Alzheimer&apos;s Disease: December 2021\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Tickled by tau? Preoccupied with post-translational modifications? Join Kate as she covers the latest papers published in December 2021 on tau protein pathology and targeting tau as a therapeutic strategy in Alzheimer's disease. \n\nSections in this episode: \nTau Aggregation & Post-Translational Modifications (3:19) \nGeneralized Tau Pathology & Tau Seeding (7:29) \nTreatments Targeting Tau in AD (13:50) "}